Literature DB >> 12211049

Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma.

Yi-Fen Wang1, Shyue-Yih Chang, Shyh-Kuan Tai, Wing-Yin Li, Liang-Shun Wang.   

Abstract

BACKGROUND: Recent studies showed that interleukin-6 (IL-6) played a role in tumor development. However, available information about the prognostic significance of IL-6 and IL-6 receptors (IL-6R) for oral squamous cell carcinoma (OSCC) is limited.
METHODS: Eighty-six patients with OSCC were enrolled. Immunohistochemical staining was used to determine IL-6R expression and in-situ hybridization for IL-6 mRNA transcripts in surgical specimens. Clinicopathologic correlation was evaluated by chi-square test and survival by log rank test.
RESULTS: Expression rates of IL-6R and IL-6 mRNA transcripts in tumor specimens were 73.3% and 54.7%, much higher than those in nontumor mucosa (p <.001). IL-6R overexpression was associated with larger tumors and more advanced histologic grade (p <.05). The presence of IL-6 mRNA transcripts was inversely correlated with distant metastasis, lymph node involvement, and second primary SCC (p <.05) and predicted better survival (p =.007).
CONCLUSIONS: IL-6-IL-6R coexpression was rather high in OSCC, and IL-6 mRNA transcript expression might influence patient survival. The biologic role of IL-6-IL-6R coexpression in OSCC needs additional investigation. Copyright 2002 Wiley Periodicals, Inc. Head Neck 24: 850-858, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12211049     DOI: 10.1002/hed.10145

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  17 in total

Review 1.  Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review.

Authors:  Moustafa Elhousiny; Kate Miller; Anura Ariyawadana; Alan Nimmo
Journal:  Clin Exp Metastasis       Date:  2019-09-26       Impact factor: 5.150

2.  Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells.

Authors:  Jacqueline A Gasche; Jürgen Hoffmann; C Richard Boland; Ajay Goel
Journal:  Int J Cancer       Date:  2011-01-07       Impact factor: 7.396

3.  Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma.

Authors:  Kristine E Day; Lauren N Beck; C Hope Heath; Conway C Huang; Kurt R Zinn; Eben L Rosenthal
Journal:  Cancer Biol Ther       Date:  2013-01-08       Impact factor: 4.742

4.  Interleukin-4 gene, but not the interleukin-1 beta gene polymorphism, is associated with oral cancer.

Authors:  Ming-Hsui Tsai; Wen-Chi Chen; Chang-Hai Tsai; Liang-Wen Hang; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

5.  In vitro cytokine release profile: predictive value for metastatic potential in head and neck squamous cell carcinomas.

Authors:  Omar Shkeir; Maria Athanassiou-Papaefthymiou; Martian Lapadatescu; Petros Papagerakis; Michael J Czerwinski; Carol R Bradford; Thomas E Carey; Mark E P Prince; Gregory T Wolf; Silvana Papagerakis
Journal:  Head Neck       Date:  2013-01-16       Impact factor: 3.147

6.  Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells.

Authors:  Kou Kayamori; Kei Sakamoto; Tomoki Nakashima; Hiroshi Takayanagi; Kei-Ichi Morita; Ken Omura; Su Tien Nguyen; Yoshio Miki; Tadahiro Iimura; Akiko Himeno; Takumi Akashi; Hisafumi Yamada-Okabe; Etsuro Ogata; Akira Yamaguchi
Journal:  Am J Pathol       Date:  2009-12-24       Impact factor: 4.307

7.  Association of interleukin-6 genetic polymorphisms with risk of OSCC in Indian population.

Authors:  Prithvi Kumar Singh; Girish Chandra; Jaishri Bogra; Rajni Gupta; Vijay Kumar; Amita Jain; Syed Rizwan Hussain; Abbas Ali Mahdi; Mohammad Kaleem Ahmad
Journal:  Meta Gene       Date:  2015-05-15

8.  Gender difference in the prognostic role of interleukin 6 in oral squamous cell carcinoma.

Authors:  Chih-Jung Chen; Wen-Wei Sung; Yueh-Min Lin; Mu-Kuan Chen; Ching-Hsiao Lee; Huei Lee; Kun-Tu Yeh; Jiunn-Liang Ko
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

9.  Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma.

Authors:  Y-F Wang; K-C Chow; S-Y Chang; J-H Chiu; S-K Tai; W-Y Li; L-S Wang
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

10.  Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma.

Authors:  Teppei Jinno; Shintaro Kawano; Yasuyuki Maruse; Ryota Matsubara; Yuichi Goto; Taiki Sakamoto; Yuma Hashiguchi; Naoki Kaneko; Hideaki Tanaka; Ryoji Kitamura; Takeshi Toyoshima; Akiko Jinno; Masafumi Moriyama; Kazunari Oobu; Tamotsu Kiyoshima; Seiji Nakamura
Journal:  Oncol Rep       Date:  2015-03-06       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.